Cargando…

Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets

Objective: Insulin-like growth factor binding protein-4 (IGFBP-4), inhibits IGF actions under a variety of experimental conditions. Parathyroid hormone (PTH), 1.25-hydroxy(OH)vitamin D, IGF-I, IGF-II and transforming growth factor (TGF)-b are the major regulators of IGFBP-4 production in vitro. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bereket, Abdullah, Cesur, Yaşar, Özkan, Behzat, Adal, Erdal, Turan, Serap, Hanedan Onan, Sertaç, Döneray, Hakan, Akçay, Teoman, Haklar, Goncagül
Formato: Texto
Lenguaje:English
Publicado: Galenos Publishing 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005664/
https://www.ncbi.nlm.nih.gov/pubmed/21274331
http://dx.doi.org/10.4274/jcrpe.v2i1.17
_version_ 1782194117930909696
author Bereket, Abdullah
Cesur, Yaşar
Özkan, Behzat
Adal, Erdal
Turan, Serap
Hanedan Onan, Sertaç
Döneray, Hakan
Akçay, Teoman
Haklar, Goncagül
author_facet Bereket, Abdullah
Cesur, Yaşar
Özkan, Behzat
Adal, Erdal
Turan, Serap
Hanedan Onan, Sertaç
Döneray, Hakan
Akçay, Teoman
Haklar, Goncagül
author_sort Bereket, Abdullah
collection PubMed
description Objective: Insulin-like growth factor binding protein-4 (IGFBP-4), inhibits IGF actions under a variety of experimental conditions. Parathyroid hormone (PTH), 1.25-hydroxy(OH)vitamin D, IGF-I, IGF-II and transforming growth factor (TGF)-b are the major regulators of IGFBP-4 production in vitro. However, little is known about the in vivo regulation of circulating IGFBP-4 in humans. Methods: We measured serum concentrations of calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), PTH, vitamin D, IGF-I, IGFBP-3, and IGFBP-4 in infants (n=22) with nutritional rickets before and after treatment of rickets with vitamin D (300 000 U single dose po). Results: The mean±SD age of the patients was 1.3±1.6 years (range 0.2-3). Serum Ca and P increased, whereas ALP and PTH decreased after treatment (Ca from 6.6±1.4 to 9.5±1.6 mg/dL, P from 3.9±1.4 to 5.4±0.8 mg/dL, ALP from 2590±2630 to 1072±776 IU/mL and PTH from 407±248 to 27.4±20.8 ng/dL, respectively). Vitamin D levels were low (7.8±2.5 ng/mL) and increased after treatment (18.1±4.0 ng/mL, p<0.001). Serum IGF-I and IGFBP-3 levels both increased after treatment (IGF-I: 13.5±12.2 vs. 23.7±14.2 ng/mL, p<0.001 and IGFBP-3: 1108±544 vs. 1652±424 ng/mL, p<0.001). However, serum IGFBP-4 levels did not change significantly after treatment (18.8±8.0 vs. 21.5±4.8 ng/mL). No correlation between PTH and IGF-I, IGFBP-3 or IGFBP-4 was detected. Significant correlations were observed between PTH and ALP (r=0.53, p<0.05), and between IGF-I and IGFBP-3 (r=0.46, p<0.05). Conclusion: The results demonstrate that contrary to in vivo studies, circulating IGFBP-4 levels are not influenced by secondary hyperparathyroidism in vitamin D deficiency rickets since IGFBP-4 levels did not change after normalization of PTH with vitamin D treatment. Conflict of interest:None declared.
format Text
id pubmed-3005664
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-30056642011-01-27 Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets Bereket, Abdullah Cesur, Yaşar Özkan, Behzat Adal, Erdal Turan, Serap Hanedan Onan, Sertaç Döneray, Hakan Akçay, Teoman Haklar, Goncagül J Clin Res Pediatr Endocrinol Original Article Objective: Insulin-like growth factor binding protein-4 (IGFBP-4), inhibits IGF actions under a variety of experimental conditions. Parathyroid hormone (PTH), 1.25-hydroxy(OH)vitamin D, IGF-I, IGF-II and transforming growth factor (TGF)-b are the major regulators of IGFBP-4 production in vitro. However, little is known about the in vivo regulation of circulating IGFBP-4 in humans. Methods: We measured serum concentrations of calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), PTH, vitamin D, IGF-I, IGFBP-3, and IGFBP-4 in infants (n=22) with nutritional rickets before and after treatment of rickets with vitamin D (300 000 U single dose po). Results: The mean±SD age of the patients was 1.3±1.6 years (range 0.2-3). Serum Ca and P increased, whereas ALP and PTH decreased after treatment (Ca from 6.6±1.4 to 9.5±1.6 mg/dL, P from 3.9±1.4 to 5.4±0.8 mg/dL, ALP from 2590±2630 to 1072±776 IU/mL and PTH from 407±248 to 27.4±20.8 ng/dL, respectively). Vitamin D levels were low (7.8±2.5 ng/mL) and increased after treatment (18.1±4.0 ng/mL, p<0.001). Serum IGF-I and IGFBP-3 levels both increased after treatment (IGF-I: 13.5±12.2 vs. 23.7±14.2 ng/mL, p<0.001 and IGFBP-3: 1108±544 vs. 1652±424 ng/mL, p<0.001). However, serum IGFBP-4 levels did not change significantly after treatment (18.8±8.0 vs. 21.5±4.8 ng/mL). No correlation between PTH and IGF-I, IGFBP-3 or IGFBP-4 was detected. Significant correlations were observed between PTH and ALP (r=0.53, p<0.05), and between IGF-I and IGFBP-3 (r=0.46, p<0.05). Conclusion: The results demonstrate that contrary to in vivo studies, circulating IGFBP-4 levels are not influenced by secondary hyperparathyroidism in vitamin D deficiency rickets since IGFBP-4 levels did not change after normalization of PTH with vitamin D treatment. Conflict of interest:None declared. Galenos Publishing 2010-03 2010-12-08 /pmc/articles/PMC3005664/ /pubmed/21274331 http://dx.doi.org/10.4274/jcrpe.v2i1.17 Text en © Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bereket, Abdullah
Cesur, Yaşar
Özkan, Behzat
Adal, Erdal
Turan, Serap
Hanedan Onan, Sertaç
Döneray, Hakan
Akçay, Teoman
Haklar, Goncagül
Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets
title Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets
title_full Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets
title_fullStr Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets
title_full_unstemmed Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets
title_short Circulating Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) is not Regulated by Parathyroid Hormone and Vitamin D in vivo: Evidence from Children with Rickets
title_sort circulating insulin-like growth factor binding protein-4 (igfbp-4) is not regulated by parathyroid hormone and vitamin d in vivo: evidence from children with rickets
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005664/
https://www.ncbi.nlm.nih.gov/pubmed/21274331
http://dx.doi.org/10.4274/jcrpe.v2i1.17
work_keys_str_mv AT bereketabdullah circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT cesuryasar circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT ozkanbehzat circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT adalerdal circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT turanserap circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT hanedanonansertac circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT donerayhakan circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT akcayteoman circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets
AT haklargoncagul circulatinginsulinlikegrowthfactorbindingprotein4igfbp4isnotregulatedbyparathyroidhormoneandvitamindinvivoevidencefromchildrenwithrickets